NCT07349160 2026-01-16
Safety and Efficacy of Metabolically Armed Tumor-Infiltrating Lymphocytes (Meta10-TIL) for the Treatment of Advanced Solid Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase EARLY_PHASE1 Recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
HighField Biopharmaceuticals Corporation
Multitude Therapeutics Inc.